Clik here to view.
Varian Medical OKs $700m share buyback
Varian Medical (NYSE:VAR) today approved the repurchasing of 8 million shares of its common stock, according to an SEC filing. The buy will cost the Palo Alto, Calif.-based company approximately $700...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 21, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Novartis backs off from 2016 date for testing Google autofocus lens
Novartis (NYSE:NVS) is reportedly backing off a 2016 start date to test its autofocusing contact lens in clinical trials, but it told Reuters that the product is “progressing steadily” in its...
View ArticleClik here to view.
FDA clears Ascensia’s Contour Next One blood glucose monitor
Ascensia Diabetes Care said today that it won FDA 510(k) clearance for its Contour Next One blood glucose monitoring system. The connected device features a blood glucose meter that links to mobile...
View ArticleClik here to view.
Tela Bio, Acelity’s LifeCell settle patent spat
Tela Bio and Acelity subsidiary LifeCell settled their patent infringement beef last month for terms that were not disclosed. Malvern, Pa.-based Tela Bio said the settlement puts to bed all state and...
View ArticleClik here to view.
Zimmer-Biomet launches VSR rotator cuff implant
Zimmer Biomet (NYSE:ZBH) said today it launched its Comprehensive Vault Reconstruction System, a patient-matched glenoid implant. The newly launched device is designed to treat patients with severely...
View ArticleClik here to view.
SuperSonic Imagine wins expanded FDA nod for Aixplorer platform
SuperSonic Imagine said today it won expanded FDA 510(k) clearance for its Aixplorer platform, including clearance for additional probes and multiple new imaging modes. The new clearance includes the...
View ArticleClik here to view.
Konica Minolta, Mindray ink deal for portable musculoskeletal ultrasound
Konica Minolta (TYO:4902) said today that it inked a partnership with Mindray Medical to bring musculoskeletal portable ultrasound solutions to the market. Wayne, N.J.-based Konica Minolta said that...
View ArticleClik here to view.
Ivenix CEO Randle looks to reboot the infusion pump
Ivenix CEO Stuart Randle began his foray into drug pump delivery systems at Baxter in 1988, when he led the company’s effort to develop the 1st needle-free IV system. More than 20 years later, when he...
View ArticleClik here to view.
Spectranetics wins CE Mark for smaller Stellarex DCB
Spectranetics (NSDQ:SPNC) said yesterday that it won CE Mark approval in the European Union for a smaller size of its Stellarex drug-coated balloon. The Stellarex 0.014” device is designed to treat...
View ArticleClik here to view.
Shockwave Medical raises $45m Series C for Lithoplasty device
Shockwave Medical said today that it raised a $45 million Series C round for the Lithoplasty device it developed to treat calcified vasular lesions. Fremont, Calif.-based Shockwave said Sectoral Asset...
View ArticleClik here to view.
FDA’s clinical investigator training helps support the drug development process
By: Leonard Sacks, M.D., and Mili Duggal, Ph.D., M.P.H. Though many people do not know it, FDA does much more to facilitate drug approval than evaluate new drug applications. We are also actively...
View ArticleClik here to view.
Medtronic shares slip on missed Q2 sales mark, lowered outlook
Medtronic (NYSE:MDT) shares dropped in pre-market trading today after the world’s largest medical device company missed Wall Street’s expectations with its fiscal 2nd-quarter sales and lowered its...
View ArticleClik here to view.
Novo Nordisk, Sanofi win FDA nods for diabetes drugs
Both Novo Nordisk (NYSE:NVO) and Sanofi (NYSE:SNY) said yesterday that they won FDA approval for pre-filled pens with drug combinations indicated for adults with Type II diabetes. Paris-based Sanofi’s...
View ArticleClik here to view.
Boston Scientific closes $210m EndoChoice buy
Boston Scientific (NYSE:BSX) said today that it closed its $210 million buyout of EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share tender offer was...
View ArticleClik here to view.
FDA clears Allergan’s Xen gel stent for glaucoma
Allergan (NYSE:AGN) said today that it won FDA approval for its Xen gel stent and injector for glaucoma. The federal watchdog indicated the drug device for the management of refractory glaucoma, in...
View ArticleClik here to view.
Mylan declines to testify at Senate committee hearing
Mylan (NDSQ:MYL) declined to testify at a U.S. Senate committee regarding its $465 million pending settlement to deal with charges that it underpaid government healthcare programs when it...
View ArticleClik here to view.
Corvia Medical touts 1-year data for InterAtrial shunt
Corvia Medical today released 1-year results from the Reduce LAP-HF clinical trial of its InterAtrial shunt device, touting a good safety profile and sustained device performance. Results from the...
View ArticleClik here to view.
Hill-Rom enters home monitoring arena with Welch Allyn hypertension program
Hill-Rom (NYSE:HRC) said today it is entering the home monitoring field as its subsidiary Welch Allyn launches its Home Hypertension program. The program will allow patients to monitor their health at...
View ArticleClik here to view.
Skyline Medical wins Health Canada nod for Streamway medical fluid disposal...
Skyline Medical said today it won Health Canada approval for its Streamway medical fluid disposal device, launching it and its associated accessories in the region. The Streamway System is an automated...
View Article